Sign in
4

Changes in Ownership

Denali Therapeutics Inc. Filed Acc 0001012975-19-000552

Director disposed of 400,000 shares (other)

  • Director acquired 2,030 shares (other)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
NELSEN ROBERT Director 2019-08-08 Other disposition −400,000 10,668,749 I: show line 1 in the form
NELSEN ROBERT Director 2019-08-08 Other acquisition +2,030 2,030 D: show line 2 in the form
Loading xslF345X03/edgar.xml…